Page last updated: 2024-08-17

mannitol and Ovarian Neoplasms

mannitol has been researched along with Ovarian Neoplasms in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (33.33)	18.7374
1990's	2 (16.67)	18.2507
2000's	5 (41.67)	29.6817
2010's	1 (8.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altorki, NK; Bender, A; Ferrara, CA; Gnjatic, S; Hoffmann, E; Jäger, E; Karbach, J; Neumann, A; Old, LJ; Weidmann, E; Yuan, J	1
Bai, J; Hu, K; Wang, Z; Yu, T	1
Choi, J; Credit, K; Flessner, MF; He, Z	1
Dragounová, E; Dvorák, J; Hyspler, R; Kalábová, H; Melichar, B; Tichá, A	1
Boerner, SA; Chianese-Bullock, KA; Coleman, E; Hogan, KT; Irvin, WP; Murphy, C; Nail, CJ; Neese, PY; Olson, WC; Petroni, GR; Slingluff, CL; Smolkin, M; Yuan, A	1
Aghajanian, C; Diefenbach, CS; Dupont, B; Dupont, J; Gnjatic, S; Hensley, ML; Iasonos, A; Jungbluth, AA; Lee, H; Old, LJ; Pezzulli, S; Sabbatini, P; Spriggs, DR	1
Andrews, PA; Barbieri, D; Ghiaroni, S; Marverti, G; Moruzzi, MS; Piccinini, G	1
Dobrynin, IaV; Kondrat'eva, NA; Merkulov, MF	1
Cvitkovic, E; Golbey, RB; Hayes, DM; Helson, L; Krakoff, IH; Scheiner, E	1
Boven, E; Holwerda, U; Pinedo, HM; Treskes, M; van der Vijgh, WJ	1
Cervantes, A; Lankelma, J; Pinedo, HM; Schuurhuis, GJ	1
Cerný, V; Petrek, C; Sándor, L; Siracký, J; Uhrínová, M; Ujházy, V; Winkler, A	1

Trials

2 trial(s) available for mannitol and Ovarian Neoplasms

Article	Year
A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer. Journal of immunotherapy (Hagerstown, Md. : 1997), 2008, Volume: 31, Issue:4 Topics: Antigens, Neoplasm; Cancer Vaccines; DNA Helicases; DNA-Binding Proteins; Dose-Response Relationship, Immunologic; Female; Humans; Immunodominant Epitopes; Interferon-gamma; Mannitol; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Oleic Acids; Ovarian Neoplasms; Peptide Fragments; Peritoneal Neoplasms; RNA-Binding Proteins; T-Lymphocytes; Treatment Outcome; Vaccination; Vaccines, Subunit	2008
Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, May-01, Volume: 14, Issue:9 Topics: Adult; Aged; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Female; HLA-A Antigens; Humans; Mannitol; Membrane Proteins; Middle Aged; Oleic Acids; Ovarian Neoplasms; Peptide Fragments	2008

Article

Year

A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer.

Journal of immunotherapy (Hagerstown, Md. : 1997), 2008, Volume: 31, Issue:4

Topics: Antigens, Neoplasm; Cancer Vaccines; DNA Helicases; DNA-Binding Proteins; Dose-Response Relationship, Immunologic; Female; Humans; Immunodominant Epitopes; Interferon-gamma; Mannitol; Melanoma-Specific Antigens; Neoplasm Proteins; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Oleic Acids; Ovarian Neoplasms; Peptide Fragments; Peritoneal Neoplasms; RNA-Binding Proteins; T-Lymphocytes; Treatment Outcome; Vaccination; Vaccines, Subunit

2008

Safety and immunogenicity study of NY-ESO-1b peptide and montanide ISA-51 vaccination of patients with epithelial ovarian cancer in high-risk first remission.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, May-01, Volume: 14, Issue:9

Topics: Adult; Aged; Antigens, Neoplasm; Cancer Vaccines; CD8-Positive T-Lymphocytes; Female; HLA-A Antigens; Humans; Mannitol; Membrane Proteins; Middle Aged; Oleic Acids; Ovarian Neoplasms; Peptide Fragments

2008

Other Studies

10 other study(ies) available for mannitol and Ovarian Neoplasms

Article	Year
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival. International journal of cancer, 2010, Feb-15, Volume: 126, Issue:4 Topics: Antigens, Neoplasm; Breast Neoplasms; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Female; Flow Cytometry; Humans; Immunotherapy; Mannitol; Melanoma; Membrane Proteins; Neoplasm Staging; Neoplasms; Oleic Acids; Oligodeoxyribonucleotides; Ovarian Neoplasms; Sarcoma; Vaccination	2010
The effect of free radical scavenger and antioxidant on the increase in intracellular adriamycin accumulation induced by ultrasound. Ultrasonics sonochemistry, 2003, Volume: 10, Issue:1 Topics: Antineoplastic Agents; Antioxidants; Ascorbic Acid; Doxorubicin; Drug Synergism; Female; Free Radical Scavengers; Histidine; Humans; Intracellular Fluid; Mannitol; Ovarian Neoplasms; Tumor Cells, Cultured; Ultrasonics	2003
Physiological characterization of human ovarian cancer cells in a rat model of intraperitoneal antineoplastic therapy. Journal of applied physiology (Bethesda, Md. : 1985), 2004, Volume: 97, Issue:4 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Injections, Intraperitoneal; Mannitol; Metabolic Clearance Rate; Neoplasms, Experimental; Ovarian Neoplasms; Rats; Rats, Nude; Tissue Distribution; Trastuzumab	2004
Gastrointestinal permeability in ovarian cancer and breast cancer patients treated with paclitaxel and platinum. BMC cancer, 2007, Aug-09, Volume: 7 Topics: Adenocarcinoma; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Cell Membrane Permeability; Cisplatin; Female; Gastrointestinal Tract; Humans; Intestinal Absorption; Lactulose; Mannitol; Middle Aged; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Paclitaxel; Sucrose; Trastuzumab; Xylose	2007
Modulation of cis-diamminedichloroplatinum (II) accumulation and cytotoxicity by spermine in sensitive and resistant human ovarian carcinoma cells. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:4 Topics: Antineoplastic Agents; Cell Membrane Permeability; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Mannitol; Ovarian Neoplasms; Polyamines; Spermine; Tumor Cells, Cultured; Tumor Stem Cell Assay	1997
[Biological properties of L-asparaginase preparations from E. coli in cell cultures]. Antibiotiki, 1978, Volume: 23, Issue:1 Topics: Asparaginase; Burkitt Lymphoma; Cell Line; DNA, Neoplasm; Drug Evaluation, Preclinical; Drug Stability; Drug Synergism; Escherichia coli; Female; Glycine; Humans; Mannitol; Ovarian Neoplasms; Thymidine	1978
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Cancer, 1977, Volume: 39, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Cisplatin; Creatinine; Diuresis; Dysgerminoma; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Hearing; Humans; Infusions, Parenteral; Injections, Intravenous; Kidney; Lung Neoplasms; Male; Mannitol; Middle Aged; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms	1977
Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse. Cancer research, 1992, Apr-15, Volume: 52, Issue:8 Topics: Amifostine; Animals; Cisplatin; Drug Administration Schedule; Female; Kidney; Liver; Male; Mannitol; Mice; Mice, Inbred BALB C; Mice, Nude; Ovarian Neoplasms; Premedication; Time Factors; Tumor Cells, Cultured; Urea	1992
The role of oxygen-derived free radicals in the cytotoxicity of doxorubicin in multidrug resistant and sensitive human ovarian cancer cells. Cancer letters, 1988, Aug-15, Volume: 41, Issue:2 Topics: Acetylcysteine; Ascorbic Acid; Benzoates; Benzoic Acid; Catalase; Cell Division; Cell Survival; Doxorubicin; Drug Resistance; Female; Free Radicals; Humans; Hydroxides; Hydroxyl Radical; Kinetics; Mannitol; Ovarian Neoplasms; Oxygen; Superoxide Dismutase; Tumor Cells, Cultured	1988
Mannitol-busulphan in advanced ovary carcinoma. Neoplasma, 1966, Volume: 13, Issue:2 Topics: Adult; Aged; Busulfan; Female; Humans; Mannitol; Middle Aged; Ovarian Neoplasms	1966